Latest Breaking News On - ஸ்விட்ச் முதுமறதி அடித்தளம் - Page 1 : comparemela.com
The Uppsala APP deletion causes early onset autosomal dominant Alzheimer s disease by altering APP processing and increasing amyloid β fibril formation
sciencemag.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencemag.org Daily Mail and Mail on Sunday newspapers.
Spinal Fluid Biomarkers Detect Neurodegeneration, Alzheimer s Disease in Living Patients
newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.
Spinal Fluid Detects Neurodegeneration, Alzheimer s in Living Patients
scienceblog.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from scienceblog.com Daily Mail and Mail on Sunday newspapers.
Jun 1, 2021
Associations seen with many CSF measures, but not beta-amyloid
Aortic stiffening was associated with cerebrospinal fluid (CSF) markers of neurodegeneration and Alzheimer’s disease, a cross-sectional study found.
“Among our oldest participants, age 74 years and older, greater aortic stiffening is associated with in vivo biomarker evidence of neuroinflammation, tau phosphorylation, synaptic dysfunction, and neurodegeneration, but not amyloidosis,” wrote Angela Jefferson, PhD, of Vanderbilt University in Nashville, Tennessee, and co-authors in
“Central arterial stiffening may lead to cumulative cerebral microcirculatory damage and blood flow delivery to tissue, resulting in neuroinflammation and neurodegeneration in more advanced age,” the researchers continued. “Collectively, our results suggest arterial stiffness does not primarily affect brain health through amyloidosis but rather through concomitant pathways of injury, though findings must be interprete
Date Time
Possible new PET tracer for early detection of Alzheimer’s
New biomarkers for Alzheimer’s disease are a priority area for researchers seeking to learn more about the disease and find possible methods of early diagnosis. Researchers at Karolinska Institutet have now studied a new PET tracer that is an important diagnostic tool for the disease. The study on the tracer substance BU99008, which is published in Molecular Psychiatry, can play a key part in the early identification of signs of Alzheimer’s disease.
The binding of the PET-tracer BU99008 shows reactive astrogliosis in different parts of the brain of a deceased patient with Alzheimer’s disease. The colours show the extent of the binding, where green is low, yellow is medium, and red is high binding. Credit: Amit Kumar.